IBRX

ImmunityBio is a biotechnology company based in San Diego that develops immunotherapy treatments designed to help the body's immune system fight cancer and infectious diseases. The company has created several experimental therapies including Anktiva, which the FDA approved to treat certain bladder cancers when combined with a standard bladder cancer drug called BCG. ImmunityBio uses platforms based on cytokine fusion proteins, DNA vectors, vaccines, and cell therapies to create new treatments, many of which are in early human testing stages. The company collaborates with research institutions…